BACKGROUND: Automated analysis of cardiac structure and function using machine learning (ML) has great potential, but is currently hindered by poor generalizability. Comparison is traditionally against clinicians as a reference, ignoring inherent human inter-and intraobserver error, and ensuring that ML cannot demonstrate superiority. Measuring precision (scan:rescan reproducibility) addresses this. We compared precision of ML and humans using a multicenter, multi-disease, scan:rescan cardiovascular magnetic resonance data set.
L eft ventricular ejection fraction (LVEF) and mass (LVM) remain key imaging biomarkers and are used daily for clinical decision-making and as clinical trial outcome measures. 1, 2 Absolute values guide pharmacotherapy, device therapy, and surgical intervention. Although it is important that measurement is accurate against some putative reference-or at least that any bias is known, it is measurement precision (repeatability) that determines the clinical smallest detectable difference with time or treatment and the sample size of clinical trials. 3 Cardiovascular magnetic resonance (CMR) imaging is the reference standard imaging modality to assess LV structure and function, and image acquisition is largely standardized through international consensus guidelines. 4 In contrast, there is less agreement about analysis techniques where significant variation exists between inclusion/exclusion of papillary muscles, trabeculae, and use of edge detection methods despite the CMR community desire for consistency and precision.
LVEF and LVM measurement variation arise from many sources including on-target changes with disease or intervention, off-target unavoidable biological variation (eg, heart rate and volume status), and avoidable intraobserver, inter-observer, inter-study, inter-center variation. These include noise (eg, intraobserver variation) and bias (one observer may systematically detect an edge differently to another), 5, 6 but relative contributions of each error source are not known.
Training programs and semi-automated contouring speed up segmentation and improve inter-observer agreement, but techniques vary considerably. [7] [8] [9] Automated analysis via machine learning (ML) approaches using deep learning neural networks show potential, 10, 11 and could remove this intra-and inter-observer variation.
Currently, ML algorithms are tested by direct comparison with human expert observers as the reference standard, however this ignores sources of human error and means that ML techniques are unable to demonstrate superiority over human techniques. Precision can only be assessed using a test:retest data set-this requires a significant sized patient cohort to be scanned twice in an identical fashion within an interval short enough to effectively exclude variation in disease biology. 5, 12, 13 For generalizability, this should be done across multiple sites and platforms.
A multi-scanner, multicenter, health and disease precision (scan-rescan) CMR data set resource for use as a tool to measure human and ML LVEF, and LVM analysis performance was collated. This resource was then used to quantify CMR precision and different sources of human error (scan acquisition, observer experience, level of automation) using multiple analysis techniques. Having understood error sources from human approaches, a deep learning convolutional neural network was trained on a large multiscanner multicenter disease cohort and explored human and ML performance. It was hypothesized that greater clinician experience and semi-automated contouring would improve human precision, and that an automated technique would have superior performance overall.
METHODS

Data Availability
The authors declare that all supporting data are available within the article and its in the Data Supplement. Details of scan-rescan data set availability are at www.thevolumesresource.com (Validation Of Left ventricular Myocardial and Endocardial Segmentation resource), intended for those wishing to benchmark future automated analysis approaches.
Study Population
The scan-rescan CMR parameters for precision assessment are outlined in Table I 
CLINICAL PERSPECTIVE
Left ventricular ejection fraction and mass remain key imaging biomarkers and are used daily for clinical decision-making and as clinical trial outcome measures. While cardiovascular magnetic resonance imaging to measure left ventricular ejection fraction is performed at high resolution, clinician analysis is remarkably variable. Automated techniques using machine learning may offer time-saving and improved confidence in absolute values, but they should be demonstrably generalizable and precise (repeatable) before widespread adoption. To address this, a multicenter, multi-vendor, multi-field strength, multi-disease cardiovascular magnetic resonance resource of 110 patients undergoing repeat imaging in a short time-frame was assembled. This was analyzed by an expert, a trained junior clinician (using five different techniques), and a fully automated convolutional neural network. This showed that clinicians can be confident in detecting a 9% change in left ventricular ejection fraction or a 20 g change in LV mass. This will be difficult to improve for clinicians because the greatest source of human error was attributable to the observer rather than modifiable factors. Having understood these errors, a convolutional neural network was trained on separate multicentre data for automated analysis and was successfully generalizable to the real-world cardiovascular magnetic resonance data. Precision was similar to human analysis, and performance was 186× faster. Automated cardiovascular magnetic resonance analysis should, therefore, be adopted globally to gain from time-saving and standardization benefits. The real-world benchmarking resource has been made available, detailed at www. thevolumesresource.com.
Heart Centre, University Hospitals Bristol, Leeds Teaching Hospitals, University College London Hospital, and University Hospitals Birmingham NHS Trusts) with 6 different MRI scanners of 2 field strengths (1.5T, 3T), 2 manufacturers (Siemens, Philips), and 3 models (Aera, Achieva, Avanto) representing the clinical spectrum (health, dilatation, hypertrophy, regional disease, n=118). Each institution obtained local approval via the United Kingdom National Research Ethics Service; the study conformed to the principles of the Helsinki Declaration, and all subjects gave written informed consent. Inclusion criteria were patients over age 18 years undergoing CMR with balanced steady-state free precession cine imaging on 2 occasions within a time-frame where biological change was not anticipated. Scans:rescans were acquired either both before or after gadolinium based contrast administration, using the same protocol, as per the international guidelines on scan acquisition. 4 Scans acquired on the same day involved removing the patient from the table and performing repeat isocenter positioning. Exclusion criteria included patients with a cardiac implantable electronic device, significant arrhythmia (atrial fibrillation or ectopy) during the scan, claustrophobia or inability to breath-hold. Allometric data were collected before the scan, and body surface area (BSA) was calculated using the Mosteller formula, Height x Weight 3600
Diagnoses were provided by the recruiting center.
CMR Scan-Rescan and Intraobserver Reproducibility
Each data set consisted of cine imaging in at least 2 long-axis orientations and a complete short-axis stack. Both scans per patient were assigned separate, randomly generated, 4-digit identification codes for blinded scan and rescan assessment.
The first scan was also duplicated and assigned a separate identification code for assessment of blinded intraobserver reassessment. Data sets were excluded (n=8) if there were missing slices or unacceptable quality on one or other acquisition judged by an expert observer (Dr Moon).
Clinician Analysis
Images were analyzed by an expert (Dr Moon) with greater than 15 years experience and 2 cardiology trainees (Drs Ye and Lau) with less than one year of experience reporting CMR. With 5 human analysis techniques, variation in performance was expected. A 3 stage process was therefore designed, Figure 1 .
Stage One
Two trainees undertook a training/standardization program over one month. Both were initially Society of Cardiovascular Magnetic Resonance level 1 accredited, and they had contoured ≈100 and 700 scans with senior clinicians respectively for the 2 observers. Contouring feedback was provided by 2 experts (Drs Moon and Manisty) and standardized instructions created (consensus-based on local practice and informed by known international standard operating procedures within UK Biobank and MESA), 14 -see tutorial video and standard operating procedures in Methods in the Data Supplement. Fifteen (different) studies ranging in difficulty were contoured and then recontoured a month later to assess training impact.
Stage Two
The 2 trainees each analyzed 10 scan-rescans of patients representing different pathologies using 5 techniques (total 200 complete LVs contoured; Methods in the Data Supplement and Figure 2 ). Techniques were (1) free-hand fully manual contouring; (2) visual thresholding of the blood-myocardial border; (3) curve fitting between points on the endocardium (click-draw); (4) level-set segmentation initialized by a midmyocardial contour; and (5) semi-automated contouring after manual centering of the LV blood-pool. To minimize the impact of learning, at least 24 hours were left between analysis using the separate techniques, and scans were analyzed in a random order for each technique.
Stage Three
This transitioned the most precise technique from stage 2 for both the expert and trainees to analyze the entire data set of 110 patients (scan A, scan B, blinded scan A again). This totaled 330 LV volumes by expert; 330 by trainees-by this time the trainees were indistinguishable in performance so they acted as one observer, dividing work; and 330 by the automated neural network). Analysis time was measured for a sample of 50 scans for one trainee and for all automated analyses.
All analyses took place using a bespoke prototype of CVI42 (Release 5.3.8 [720], Circle, Calgary, Canada) to include a novel level-set segmentation technique previously developed and implemented for fractal analysis and modified in this study for endocardial contouring. 15 End diastolic (ED) and end systolic (ES) phases were defined as the largest and smallest long-axis ventricular volumes visually. Contiguous short-axis slices were delineated in ED (endocardium first then epicardium) and ES (endocardium) to derive LV end diastolic volume (EDV), end systolic volume (ESV), stroke volume (SV), ejection fraction (LVEF) and LVM, with allometric scaling using body surface area. To address basal slice variability, blood volume was included if there was over 50% of LV myocardium surrounding blood-pool, and a long-axis atrioventricular plane correction was used. The left ventricular outflow tract was included in the blood volume.
Automated Neural Network Training and Analysis
An automated 2-dimensional deep fully convolutional neural network was previously developed to predict LV endocardial and epicardial contours at ED and ES from an input CMR steady-state free precession short-axis stack. 10 The network was previously trained on 4875 subjects from the UK Biobank, however performance was not easily generalizable to multicenter, multi-disease data. So, the network was trained from scratch on 599 multicenter, multi-scanner data sets of patients with severe aortic stenosis, as described elsewhere. 16 Although this cohort represents one primary disease, extensive comorbidity (hypertension ≈53%, diabetes mellitus ≈22%, coronary artery disease ≈29%), and the ventricular response (≈50% with focal scar, ≈60% with hypertrophy [3 different subtypes], ≈20% with impairment) made it representative of human cardiac disease in general. These 599 scans (comprising ≈13 cines, each 25 frames 195 000 images) were annotated at ED and ES by an expert observer (Dr Moon). Annotations were performed after the standardized post-processing guidelines above. Papillary muscles and trabeculations were included in the LV blood-pool. Training of the network took 8 hours 40 minutes on a Nvidia Titan X GPU.
Statistics
Data were analyzed in R (R foundation, Vienna, Austria) using RStudio Server version 0.98 (Boston, Mass). All continuous variables are expressed as mean±SD or median (interquartile range) for skewed data. Categorical variables are expressed as frequencies in percent. Multiple groups were compared using one-way ANOVA.
For inter-observer agreement, an intraclass correlation coefficient (Lin's concordance correlation coefficient) was used which reflects both agreement and deviation from the line of perfect concordance; <0.2=poor, >0.8=excellent agreement. 17 To quantify reproducibility, 3 metrics were used: the absolute difference between scans, Bland-Altman limits of agreement, and within-subject Coefficient of variation (CV). 18 The within-subject variance was bootstrapped (1000 bootstraps) to estimate a 95% CI of the CV.
For a head-to-head comparison of scan-rescan precision between techniques or operators, linear mixed effects regression models were used, which account for multiple observers analyzing multiple measures per subject. Models were run separately for each LV metric (EDV, ESV, SV, LVEF, or LVM) as the dependent variable. To assess training, the dependent variable was the difference between expert and trainee, and the fixed effect was training category (before/after). To assess technique, the dependent variable was the LV metric, and the fixed effects were technique and scan-rescan category (1 or 2). An interaction between technique and scan category was used to assess scan-rescan precision for each technique. 19 To assess different operators, the dependent variable was the LV metric, and the fixed effects were operator, scan-rescan category and the interaction term of operator and scan-rescan Sample size required to detect a clinical change was calculated from the standardized difference (d) in each LV metric with a power of 90% and α of 0.05, where d is the desired clinical change divided by the SD of scan-rescan differences. The SE of measurement was calculated as the square root of the mean squared error obtained from one-way ANOVA. The minimal detectable change between 2 scans considered to be different was calculated as 2×SE of measurement. All tests were 2-tailed, and P<0.05 was considered statistically significant.
RESULTS
Scan-Rescan Cohort
The final data set of 110 scan-rescans represented patients with myocardial infarction (n=32), left ventricular hypertrophy (n=17, including hypertrophic cardiomyopathy), cardiomyopathy (n=17, dilated, arrhythmogenic right ventricular and left ventricular noncompaction cardiomyopathies), other pathology (n=14, cardio-oncology follow-up and chronic kidney disease), and healthy volunteers (n=30). All LV metrics differed significantly between diagnostic sub-groups, Table 1 . One hundred six rescans (96%) were performed within one week (82% on the same day); 4 scans in healthy volunteers were performed between 1 week and 3 months.
Impact of Initial Training on Trainee-Expert Agreement
Training and implementation of a standard operating procedure significantly improved agreement between trainees and an expert for all LV metrics, Table II in the Data Supplement.
Impact of Techniques on Human Accuracy (Bias) and Precision
The thresholding and semi-automated techniques did not show a difference in accuracy with reference to manual contouring. As expected, the other 2 techniques showed over/under-estimation in EDV, ESV, and LVM; but not LVEF or SV: the click-draw technique measured the LV as larger and showed a trend to lower LVM (EDV 6.0±2.9 mL, P=0.0449; ESV 5.0±2.0 mL, P=0.0133; and LVM −6.7±3.6 g, P=0.0671); the levelset technique measured the LV as smaller and LVM as higher (EDV −8.3±2.9 mL, P=0.0056; ESV −5.8±2.0 mL, P=0.0042); LVM 15±4.3 g, P<0.0004).
For precision, however, there was no significant difference between techniques for either observer, Table III in the Data Supplement. This included both techniques that included papillary muscles in the blood-pool and those that included them within the myocardial mass, Figure 2 . Given the similar precision between techniques, subsequent analysis of the complete data set by the expert and trainee used the thresholding technique, because it showed fewer large mistakes requiring manual correction.
Expert, Trainee and Automated Accuracy (Bias), Precision and Speed
There was good agreement between expert and trainee (intraclass correlation coefficients, 0.92-0.98) and automated analysis (intraclass correlation coefficients, 0.90-0.98) for all LV metrics, Figures I and II in the Data Supplement. Compared with expert analysis, trainee analysis measured the LV as slightly smaller, and LVEF and LVM as slightly higher. Automated analysis, conversely, measured the LV as slightly larger, and LVEF and LVM as slightly lower, Table IV in the Data Supplement. For precision, however, there was no significant difference between expert, trainee and automated analysis for all LV metrics, Table V in the Data Supplement.  Table 2 and Figure 3 detail scan-rescan and intraobserver differences, Bland-Altman limits of agreement, and CV.
Human analysis time was 13 (interquartile range, 9-19) minutes per scan. Automated analysis time of a 25-phase short-axis stack was ≈0.07 minutes.
Sources of Error for Human and Automated Techniques
Average human CV for intraobserver, inter-observer and scan-rescan reproducibility were, for LVEF: 5.3%, 6.3%, and 7.2%, and for LVM: 4.6%, 7.6%, and 5.5% respectively, Figure 4 and Figure 5 . For all LV metrics, human intraobserver CV was greater than half of the scan-rescan CV. For humans, scan-rescan CV was the greatest source of error for EDV, ESV, SV, and LVEF, while inter-observer error was the greatest source of error for LVM, Table VI in the Data Supplement. For automated analysis, there was zero intraobserver error as this technique was nonstochastic, that is, with the same image, the network would always generate an identical result. For all observers, precision was not influenced by the degree of impairment in LVEF.
Sample Size Estimates and Minimal Detectable Change
Calculation of sample size from these data shows that CMR requires 28 patients to detect a 3% change in LVEF; 12 patients to detect a 10 g change in LVM; and 17, 10, and 16 patients to detect a 10 mL change in EDV, ESV, and SV, respectively, Table 3 . The percentage change in sample size of an expert for all LV metrics was similar to a trainee (×1.2-1.5) and automated analysis (×0.8-1.5). Sample size requirements were largest for patients with left ventricular hypertrophy.
For an individual patient, the minimal detectable change was 8.7% in LVEF or 20 g in LVM, based on expert analysis (with no difference when compared with automated analysis).
DISCUSSION
Despite reliance on measurements of LVEF and LVM for clinical decision-making and as end points in research studies, analysis is often not standardized and the relative contributions of error sources are imperfectly known. These data show that using current standardized image acquisition and multicenter, multi-vendor, multi-field strength, multi-disease, scan-rescan data at scale, measurement error was largely due to inconsistency in the human observer rather than variation in modifiable factors-clinician experience, scan acquisition, or human contour strategy (here performed using 5 techniques). This study also demonstrated for the first time that an automated analysis technique using deep learning has equivalent precision (scan-rescan reproducibility) to an expert, and yielded ≈13 minutes time-saving per scan, tested head-to-head on variable pathologies from multiple institutions. Clinicians can be confident in detecting a 9% change in LVEF or a 20 g change in LVM, this was similar if using an automated ML technique. Because the resource has the potential to test superiority of automated over human analysis, 
scan-rescan data and training videos/standard operating procedures have been made available.
Previous studies investigating LV analysis by CMR have largely focused on inter-observer and intraobserver differences, usually using data sets from healthy individuals in single centers. 5, 6 Clinical practice relies on scan-rescan precision, and includes sources of variation not previously captured in most data sets such as the scan acquisition, differences between institution, and disease states. This study looked at the efficacy of a number of potential strategies (decided a priori) that might reduce or maintain variability with time-saving through automation: clinician experience, training, human contouring methods, and deployment of an automated neural network segmentation approach.
Benefits of Automated Analysis
The adoption of ML can offer comparable precision with clinicians, with the time saving and global standardization that would ensue. Training of junior clinicians required a month-long program, compared with ≈9 hours for a neural network. Once trained, clinicians required an average of 13 minutes for analysis per scan, compared with ≈4 seconds for a neural network. In the UK, an estimated 2275 scans per million adults are needed annually, performed in 61 centers. 20 Automating this one aspect of CMR analysis alone would, therefore, potentially translate into a saving of 54 clinician-days per center. Accurate automated segmentation is a bridge to reliable extraction of more information from the same imaging beyond Analysis is by 3 observers (rows) over 3 data sets (columns), with average analysis timing per scan per observer reported. Left column: original scan 1, middle column: blinded scan 1 re-analysis; right column: repeat scan 2. Note this is one phase of one slice of ≈10 in each short-axis stack; that all human contours differ whereas the automated neural network scan 1 blinded reanalysis contours are identical. Note also the similar position but different piloting and orientation of the repeat scan 2. established imaging biomarkers. In combination with time saving, this maximizes use of acquired data in a value-based manner.
ML Techniques can Surpass Human Precision
Given that the greatest sources of measurement error were human factors (ie, nonmodifiable intra-and interobserver variability), we believe that, with improvement, it is only a matter of time before automated approaches are super-human, with cascading consequences in clinical (confidence, smallest detectable difference) and research (trial size) domains of increased precision. Improvement could be related to either training data or the network itself, and comparison of scan-rescan precision against that of an expert offers the ability to show superior performance, and provides an important validation step towards real-world scalability.
Similar performance of automated techniques to humans has previously been shown by comparing the degree of inter-observer agreement between 2 clinicians and clinician-network agreement in typi-cally healthy subjects. 10, 11 Evaluation of new automated segmentation techniques is typically performed against expert ground truth in medical imaging grand challenge data sets, and presented as contour comparisons (such as mean error or dice index). 21, 22 Expert segmentation for the ground truth comparisons is time consuming meaning cases numbers are necessarily small, limited to a few centers and pathologies, and such metrics are not intuitive for clinicians. 6 UK Biobank data and the MICCAI ACDC 2017 challenge have addressed issues of cohort size and differences between scanners, but using this approach it is not possible to identify a technique that is superior to human analysis, despite growing appreciation of the high intra-and inter-observer variability in human measurements. 6, 10, 11 Comparison of measurement precision between techniques using test:retest methodology avoids this limitation, and this cohort enables identification of methods that are both generalizable and superior to humans.
Superior performance will require potentially larger and more variable pathology datasets facilitated by adversarial training, or transfer learning. 23, 24 However, if training is performed by one expert annotating each dataset, neural networks will be trained to minimize between subject differences, but not differences between or within observers. Training on repeated measures may minimize these errors. This could also be surmounted by the use of stronger priors, 25 3D neural networks or even limiting the reliance on annotation through deeper, more intelligent pixel classification.
Neural network approaches, however, do show limitations. Data must be standardized before analysis, and neural networks are computationally expensive to train and require clinician-facing interfaces before widespread implementation. Biologically implausible segmentations are also possible and therefore results require human review. 11
Sample Size Estimates
This study provides benchmark precision metrics that reflect a range of pathologies and institutions. Required sample sizes to detect a standardized difference was greatest for patients with left ventricular hypertrophy who had increased LVM and small systolic cavity volumes. The sample size required to detect a clinically important change was between 10 and 28 patients for different LV metrics, which is higher than previous estimates. 5, 12, 13 This data set however is different due to its high variability, and should these results be considered for future study design, there may be reasons that these results either over-or under-represent anticipated performance for a specific real-world task. Factors that make precision higher here include: excellent training/ For ejection fraction, human error (coefficient of variation) is incremental from intraobserver, inter-observer (on the same scan), to inter-scan. For mass, human inter-observer error is greatest. Scan-rescan error is similar for human and automated neural network analysis, however the majority of error for human analysis is related to the observer suggesting that automated techniques have other sources that can be addressed to surpass human performance. Human error is the average of both human observers. standardization and operator selection; bias from using only the best 110 studies from 118 with (by definition) no further dropout; scan-rescan at short time intervals; a few expert centers only. Factors that make precision lower here include: inclusion of multiple diseases; multiple centers; multiple scanners and blinded analysis. While follow-up studies may be analyzed consecutively in clinical practice, we ensured that the 2 scans acquired for each subject were assigned different randomized study numbers to minimize bias in this study. There was no review of study data at study completion, with all analyzed data sets included in the results.
Sources of Human Measurement Error
It is generally accepted that there is incremental variation from intraobserver, inter-observer and scan-rescan (physiological and technical) differences. 26 These data For Trainee and Automated neural network analysis, sample size is represented as a proportional change to Expert analysis. Sample size estimates stratified by pathology are presented for expert analysis only.
CM indicates cardiomyopathy; EDV, end diastolic volume; EF, ejection fraction; ESV, end systolic volume; HV, healthy volunteers; LVH, left ventricular hypertrophy; MI, myocardial infarction; SD, standard deviation; and SV, stroke volume. demonstrated that human (intraobserver) error (CV) was greater than half of scan-rescan error, an effect that was not minimized by an expert when compared with junior clinicians after appropriate training, despite 15 years' additional experience. A training program combined with standard operating procedures was an effective approach to improve inter-observer agreement, by standardizing basal blood volume and papillary muscles, as previously reported. 7, 8 Semi-automated techniques, including a novel level-set approach with minimal user interaction also did not improve precision over manual techniques, a finding replicated in 2 observers. However, human contour strategies resulted in potentially clinically relevant differences for an individual patient, emphasizing the need to interpret reference ranges in the context of the technique from which they were derived.
To improve human measurement precision, an improved focus on unifying a systematic approach to analysis and greater acquisition standardization appears important. This would require investigating piloting of the short-axis cine stack, loading conditions, or sequence improvements that improve myocardial contrast with epicardial fat. 27
Study Limitations
We measured variability using a relatively small number of observers, however by including both trainees and an international expert as the gold standard observer, the errors measured are likely to be representative. Both scans for each patient were acquired in the same institution using the same protocol, and therefore we have not assessed scan-rescan precision between institutions. The scan-rescan interval was short (with 82% of studies acquired on the same day), and we are, therefore, unable to assess the contribution of physiological variability across months or years. The precision of right ventricular assessment was not within the scope of this study. We analyzed the performance of a ML approach but not its prospective clinical application.
CONCLUSIONS
Automated ML techniques for LV analysis match human precision and perform substantially faster. Based on multicenter, multi-vendor, multi-field strength, multidisease data, a 9% change in ejection fraction can be detected confidently by expert clinicians, and this is similar using automated analysis. Given that a major source of measurement variability is attributable to the observer, automated approaches offer the future potential to surpass human experts, demonstrable using this scan-rescan resource.
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